|
SPORE in Lymphoma
|
5P50CA126752-05
|
$2,153,287
|
$602,920
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
$58,695
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-04
|
$308,958
|
$308,958
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
5R01CA047006-24
|
$554,148
|
$277,074
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of EBV Infection
|
5R01CA068051-16
|
$454,973
|
$45,497
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-02
|
$188,304
|
$1,883
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-06A1
|
$2,185,000
|
$1,092,500
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-24
|
$349,765
|
$3,498
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
|
5U01CA105388-08
|
$841,281
|
$143,018
|
LOWE, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
2P30CA045508-24
|
$4,306,037
|
$86,121
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies
|
1R01CA161026-01
|
$449,734
|
$224,867
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INSTITUTE
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-18
|
$1,781,177
|
$160,306
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-37S1
|
$37,988
|
$380
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-37
|
$5,723,821
|
$57,238
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-37S2
|
$75,000
|
$750
|
MEANS, ANTHONY
|
DUKE UNIVERSITY
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-28
|
$450,001
|
$4,500
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
|
5U10CA038926-26
|
$4,603,957
|
$46,040
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
|
5R01CA140754-02
|
$574,828
|
$287,414
|
Johnson, Christine C
|
HENRY FORD HEALTH SYSTEM
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
5R01CA098285-08
|
$490,125
|
$490,125
|
ALT, FREDERICK
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-36
|
$2,820,874
|
$705,219
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Novel Biologic Therapies for Hodgkin's Lymphoma
|
5K23CA124465-04
|
$140,940
|
$140,940
|
KASAMON, YVETTE
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-48S3
|
$6,995,274
|
$139,905
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-48S4
|
$75,000
|
$1,500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
BETR Therapy for Herpesvirus-Associated Tumors
|
5R01CA138636-02
|
$553,505
|
$276,753
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
|
3U10CA128567-03S2
|
$459,779
|
$4,598
|
MILLS, GLENN
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
Southwest Oncology Group
|
5U10CA046282-24
|
$338,795
|
$3,388
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
Signal transduction inhibitor therapy for Lymphoma
|
5R01CA127433-05
|
$325,779
|
$162,890
|
Witzig, Thomas
|
MAYO CLINIC
|
|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$245,990
|
N/A
|
National Cancer Institute
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-09S3
|
$1,375,035
|
$13,750
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-09
|
$26,766,352
|
$267,664
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-09
|
$5,780,843
|
$57,808
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-10
|
$1,464,654
|
$14,647
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
2U24CA114766-06
|
$817,102
|
$81,710
|
RAMIREZ, NILSA
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
3U24CA114766-05S2
|
$378,516
|
$37,852
|
Ramirez, Nilsa
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Molecule-Guided Investigations into p53 Biology
|
ZIA BC 011261
|
$289,758
|
$43,463
|
Bernal, Federico
|
CCR (NCI)
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$55,940
|
$8,391
|
Bishop, Michael
|
CCR (NCI)
|
|
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$55,940
|
$11,188
|
Bishop, Michael
|
CCR (NCI)
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
ZIA SC 010365
|
$74,587
|
$14,917
|
Bishop, Michael
|
CCR (NCI)
|
|
CLL Families-Mayo
|
ZIA CP004410-10312
|
$77,034
|
$3,851
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$863,668
|
$259,100
|
Cowen, Edward
|
CCR (NCI)
|
|
Cancer following bone-marrow transplantation
|
ZIA CP010131-04020
|
$135,580
|
$13,557
|
Curtis, Rochelle
|
DCEG (NCI)
|
|
Antibody-based therapeutics and vaccines against AIDS
|
ZIA BC 011155
|
$178,463
|
$89,231
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010150-10071
|
$170,909
|
$25,636
|
Engels, Eric
|
DCEG (NCI)
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150-10359
|
$116,720
|
$23,344
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$130,864
|
$13,086
|
Engels, Eric
|
DCEG (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,801,787
|
$240,089
|
Fojo, Antonio
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$218,895
|
$21,889
|
Fowler, Daniel
|
CCR (NCI)
|
|
Microbial diversity and human malignancy
|
ZIA CP010214-10419
|
$180,616
|
$36,123
|
Goedert, Jim
|
DCEG (NCI)
|
|
Hodgkin's families
|
ZIA CP004410-08167
|
$76,692
|
$72,857
|
Goldin, Lynn
|
DCEG (NCI)
|
Total relevant funding to Hodgkins disease for this search: $13,379,528
|